Wang, Rui
Tang, Ruqi
Li, Bo
Ma, Xiong
Schnabl, Bernd
Tilg, Herbert http://orcid.org/0000-0002-4235-2579
Funding for this research was provided by:
National Natural Science Foundation of China (81830016, 81771732, 81620108002, 81922010, 81873561)
U.S. Department of Health & Human Services | NIH | Center for Scientific Review (P30 DK120515, P50 AA011999)
U.S. Department of Health & Human Services | NIH | Center for Scientific Review
Bundesministerium für Verkehr, Innovation und Technologie (the excellence initiative VASCage (Centre for Promoting Vascular Health in the Ageing Community), an R&D K-Centre (COMET program - Competence Centers for Excellent Technologies))
the Austrian Ministry for Digital and Economic Affairs and the federal states Tyrol, Salzburg and Vienna.
Article History
Received: 3 September 2020
Accepted: 8 November 2020
First Online: 14 December 2020
Competing interests
: B.S. has been consulting for Ferring Research Institute, Intercept Pharmaceuticals, HOST Therabiomics, Mabwell Therapeutics and Patara Pharmaceuticals. B.S.’s institution (UC San Diego) has received grant support from BiomX, NGM Biopharmaceuticals, CymaBay Therapeutics, Synlogic Operating Company and Axial Biotherapeutics. H.T. and X.M. have no competing interests.